Genenta Science (GNTA) Stock Chart & Stock Price History → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free GNTA Stock Alerts $3.30 +0.12 (+3.77%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Genenta Science Stock Price Performance5 Day Performance+3.12%1 Month Performance-15.41%3 Month Performance-26.50%6 Month Performance-39.45%Year-To-Date Performance-33.33%1 Year Performance-46.77% Receive GNTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genenta Science and its competitors with MarketBeat's FREE daily newsletter Email Address Ad The Freeport SocietyBiden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. GNTA Stock Chart for Monday, May, 20, 2024 GNTA Chart by TradingView Genenta Science Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$3.18$3.27+2.83%$3.34$3.251,686 shs$59.58 million05/16/2024$3.20$3.18-0.63%$3.38$3.181,341 shs$57.94 million05/15/2024$3.22$3.20-0.62%$3.37$3.003,556 shs$58.30 million05/14/2024$3.51$3.22-8.15%$3.50$3.112,070 shs$58.67 million05/13/2024$3.10$3.51+13.09%$3.51$3.171,082 shs$63.88 million05/10/2024$3.23$3.10-4.02%$3.30$3.1017,777 shs$56.47 million Get the Latest News and Ratings for GNTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genenta Science and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$3.70$3.23-12.70%$4.22$3.1831,590 shs$58.84 million05/08/2024$3.42$3.70+8.19%$3.80$3.56989 shs$67.40 million05/07/2024$3.49$3.42-2.01%$3.68$3.373,259 shs$62.30 million05/06/2024$3.47$3.49+0.49%$3.50$3.181,649 shs$63.59 million05/03/2024$3.31$3.47+4.83%$3.47$3.47317 shs$63.22 million05/02/2024$3.29$3.31+0.61%$3.50$3.084,153 shs$60.30 million05/01/2024$3.08$3.29+6.82%$3.30$3.292,170 shs$59.94 million04/30/2024$2.95$3.08+4.41%$3.08$2.902,765 shs$56.12 million04/29/2024$2.59$2.95+13.90%$3.30$2.555,092 shs$53.75 million04/26/2024$2.91$2.59-11.12%$2.95$2.498,097 shs$47.19 million04/25/2024$2.55$2.91+14.28%$2.98$2.6711,459 shs$53.10 million04/24/2024$3.63$2.55-29.75%$3.70$2.2062,678 shs$46.46 million04/23/2024$3.95$3.63-8.02%$3.89$3.61679 shs$66.13 million04/22/2024$3.90$3.95+1.17%$3.97$3.601,251 shs$71.91 million04/19/2024$3.92$3.90-0.37%$3.93$3.386,415 shs$71.08 million04/18/2024$3.24$3.92+20.85%$3.92$3.154,385 shs$71.33 million04/17/2024$3.43$3.24-5.60%$3.37$3.001,551 shs$59.03 million04/16/2024$3.37$3.43+2.00%$3.43$3.252,992 shs$62.54 million04/15/2024$3.47$3.37-2.92%$3.47$3.372,122 shs$61.31 million04/12/2024$3.47$3.47$3.47$3.4010,081 shs$63.22 million04/11/2024$3.41$3.47+1.76%$3.50$3.475,118 shs$63.22 million04/10/2024$3.31$3.41+3.02%$3.41$3.162,411 shs$62.13 million04/09/2024$3.30$3.31+0.30%$3.36$3.2212,628 shs$60.30 million04/08/2024$3.28$3.30+0.51%$3.58$3.284,450 shs$60.13 million04/05/2024$3.29$3.28-0.30%$3.47$3.162,327 shs$59.76 million04/04/2024$3.31$3.29-0.50%$3.43$3.29776 shs$59.93 million04/03/2024$3.34$3.31-1.00%$3.40$3.314,553 shs$60.25 million04/02/2024$3.61$3.34-7.48%$3.50$3.34961 shs$60.86 million04/01/2024$3.50$3.61+3.14%$3.61$3.61202 shs$65.77 million03/29/2024$3.50$3.50$3.86$3.307,416 shs$63.76 million03/28/2024$3.66$3.50-4.37%$3.86$3.307,416 shs$63.77 million03/27/2024$3.80$3.66-3.58%$3.95$3.503,224 shs$66.69 million03/26/2024$3.93$3.80-3.47%$3.88$3.514,357 shs$69.16 million03/25/2024$4.00$3.93-1.69%$3.95$3.902,424 shs$71.65 millionNext President (Not Trump. Not Biden.) (Ad)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________.03/22/2024$4.00$4.00$4.00$4.00316 shs$72.88 million03/21/2024$4.10$4.00-2.44%$4.20$3.9155,414 shs$72.88 million03/20/2024$4.10$4.10$4.10$4.071,592 shs$74.70 million03/19/2024$4.11$4.10-0.24%$4.10$3.992,215 shs$74.69 million03/18/2024$3.90$4.11+5.38%$4.19$3.8825,835 shs$74.88 million03/15/2024$4.00$3.90-2.50%$3.90$3.90204 shs$71.06 million03/14/2024$4.16$4.00-3.76%$4.10$3.702,354 shs$72.88 million03/13/2024$4.35$4.16-4.46%$4.39$3.987,008 shs$75.73 million03/12/2024$3.97$4.35+9.52%$4.35$4.35402 shs$79.26 million03/11/2024$3.97$3.97$3.97$3.9740 shs$72.37 million03/08/2024$4.05$3.97-1.85%$4.29$3.925,216 shs$72.33 million03/07/2024$4.05$4.05-0.12%$4.19$3.926,375 shs$73.70 million03/06/2024$4.00$4.05+1.25%$4.19$3.926,375 shs$73.79 million03/05/2024$4.10$4.00-2.44%$4.25$4.002,974 shs$72.87 million03/04/2024$4.19$4.10-2.15%$4.38$4.10613 shs$74.70 million03/01/2024$4.40$4.19-4.77%$4.22$4.102,557 shs$76.34 million02/29/2024$4.40$4.400.00%$4.40$4.4021 shs$80.17 million02/28/2024$4.15$4.40+6.02%$4.40$4.11644 shs$80.17 million02/27/2024$4.17$4.15-0.48%$4.15$4.15265 shs$75.61 million02/26/2024$3.90$4.17+6.92%$4.49$4.171,389 shs$75.98 million02/23/2024$4.11$3.90-5.11%$4.14$3.90539 shs$71.06 million02/22/2024$4.40$4.11-6.59%$4.13$4.111,065 shs$74.88 million02/21/2024$4.49$4.40-2.00%$4.50$4.402,374 shs$80.17 million02/20/2024$4.42$4.49+1.58%$4.90$4.0011,090 shs$81.79 million02/19/2024$4.42$4.42$4.42$4.38400 shs$80.53 million Related Companies: AVROBIO Stock Chart Cidara Therapeutics Stock Chart LENZ Therapeutics Stock Chart Ikena Oncology Stock Chart Aligos Therapeutics Stock Chart Turnstone Biologics Stock Chart Protara Therapeutics Stock Chart IN8bio Stock Chart Entera Bio Stock Chart Atara Biotherapeutics Stock Chart Receive GNTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genenta Science and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GNTA) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genenta Science S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.